A team from the Universitat Politècnica de València has just published a study analyzing the potential of plant extracts and/or natural compounds to inhibit the protease activity of the SARS-CoV-2 coronavirus. According to Carla Guijarro, a researcher at the UPV’s…
Read More
Potential biomarker found for lung disease in scleroderma patients
Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma. The recent study, published in Arthritis Care & Research and investigated by a Michigan Medicine researcher, found a novel adipokine, known…
Read More
Researchers identify potential approach to controlling epileptic seizures
Researchers from Case Western Reserve University have identified a potential new approach to better controlling epileptic seizures. Lin Mei, professor and chair of the Department of Neurosciences at the Case Western Reserve School of Medicine, who led the new study…
Read More
Discovery of potential new combination therapy for leukemia
WEHI researchers have discovered why some leukemia cells are resistant to new “SMAC-mimetic’ anti-cancer agents, a finding which could improve the use of these drugs in the clinic. The team discovered that the ‘drug pump’ protein MDR1 makes acute myeloid…
Read More
Potential COVID-19 treatment identified
A collaboration among scientists from UCLA and other universities in California, Delaware and Germany, as well as a German pharmaceutical company, has singled out a compound that shows promise for treating SARS-CoV-2, the virus that causes COVID-19. In a series…
Read More
Researchers identify drugs with potential to stop plaque buildup in arteries
Glycomics researchers at the University of Alberta and CHU Sainte-Justine have reported a discovery that could lead to new treatments for cardiovascular disease. The researchers identified a new mechanism responsible for the buildup of plaque on artery walls, a process…
Read More
Potential combined drug therapy for lung cancer
Most lung cancers are of a type called non-small-cell lung carcinoma (NSCLC). This type of cancer is relatively insensitive to chemotherapy, so NSCLC therapies are usually based on drug treatment. Alectinib is a drug commonly used for treating patients with…
Read More
Biden plan to reopen schools subject to potential changes in coronavirus pandemic, official says
President Biden to roll out coronavirus strategy amid pandemic Fox News medical contributor Dr. Marty Makary weighs in on ‘America’s Newsroom.’ One of President Biden’s goals for his first 100 days in office is to see to it that most…
Read More
Potential treatment approach kills lymphoma while sparing healthy cells
Scientists at Scripps Research have demonstrated a promising new strategy for treating lymphomas, a group of cancers that begin in infection-fighting cells of the immune system called lymphocytes. The new approach uses natural cancer-targeting immune cells, known as natural killer…
Read More
Potential cancer therapy may boost immune response
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according to a study led by…
Read More